Helios Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.85M Hold
1,600
– – 2.01% 13
2026
Q2
$1.92M Buy
+1,600
New +$1.63M 1.87% 15
2025
Q3
– Sell
-2,000
Closed -$1.56M – 37
2025
Q2
$1.56M Hold
2,000
– – 1.2% 22
2025
Q1
$1.65M Hold
2,000
– – 2.89% 6
2024
Q4
$1.54M Hold
2,000
– – 0.9% 22
2024
Q3
$1.77M Hold
2,000
– – 1.09% 22
2024
Q2
$1.81M Hold
2,000
– – 1.18% 23
2024
Q1
$1.56M Hold
2,000
– – 1.09% 24
2023
Q4
$1.17M Buy
+2,000
New +$1.17M 0.92% 27

Other funds holding LLY

Helios Capital Management's LLY Position: Q3 2026 in Review

Helios Capital Management held its Eli Lilly (LLY) position steady in Q3 2026 at 1,600 shares worth $1.85M. The position accounts for 2.01% of the portfolio, ranked #13.

Helios Capital Management first reported a position in LLY in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.92M in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Helios Capital Management held 1,600 shares of Eli Lilly worth $1.85M as of Q3 2026.
  • Helios Capital Management left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 2.01% of Helios Capital Management's portfolio in Q3 2026, its #13 holding.
  • Helios Capital Management first reported a position in Eli Lilly in Q4 2023 and has held it in 9 quarters since.
  • Helios Capital Management's Eli Lilly position peaked at $1.92M in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Helios Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.